Y. Bohbot , F. Sanguineti , C. Renard , T. Hovasse , I. Limouzineau , T. Unterseeh , C. Di Lena , W. Boukefoussa , C. Tawa , S. Duhamel , P. Garot , C. Tribouilloy , J. Garot
{"title":"Associated factors and clinical implications of dynamic changes in late gadolinium enhancement after acute myocarditis","authors":"Y. Bohbot , F. Sanguineti , C. Renard , T. Hovasse , I. Limouzineau , T. Unterseeh , C. Di Lena , W. Boukefoussa , C. Tawa , S. Duhamel , P. Garot , C. Tribouilloy , J. Garot","doi":"10.1016/j.acvdsp.2023.04.011","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p><span>Although follow-up cardiac magnetic resonance (CMR) is often performed after acute </span>myocarditis<span> (AM), the prognostic implications of dynamic changes in late gadolinium enhancement (LGE) are unknown. We aimed to determine the prognostic implications of dynamic LGE changes after acute AM.</span></p></div><div><h3>Method</h3><p>In a two-centre study, 204 consecutive hemodynamically stable patients (mean age 35<!--> <!-->±<!--> <span>16 years, 78.9% males) with a CMR-based diagnosis of AM were included and underwent repeat CMR 3–12 months after diagnosis. Quantitative LGE was expressed as percent of left ventricular (LV) myocardium<span>. The primary endpoint was the occurrence of major adverse cardiac events (MACE) at median 7.3 [IQR: 5.7–8.7] years.</span></span></p></div><div><h3>Results</h3><p><span>Compared to index CMR, there was an increase in LV ejection fraction (EF) (59% vs. 55%, </span><em>P</em> <!--><<!--> <!-->0.001) and a decrease in LGE extent (7.6% vs. 12.0%, <em>P</em> <!--><<!--> <!-->0.001) at follow-up (mean 5.7<!--> <!-->±<!--> <!-->2.6 months after index CMR). LGE persisted in 175 patients at follow-up (85.8%). LGE decreased by ≥ 50% from baseline in 94 patients (46%), by < 50% in 86 (42%) and increased in 24 (12%). Female gender (OR [95%CI]<!--> <!-->=<!--> <!-->3.27 [1.17–9.12], <em>P</em> <!-->=<!--> <!-->0.023), low baseline LVEF (OR [95%CI]<!--> <!-->=<!--> <!-->0.93 [0.88–0.98] per %, <em>P</em> <!-->=<!--> <!-->0.010) and LGE involving both septal and lateral walls (OR [95%CI]<!--> <!-->=<!--> <!-->4.64 [1.77–12.17], <em>P</em> <!-->=<!--> <span>0.002) were independently associated with increased LGE. By multivariate Cox analysis, only baseline LVEF (HR [95%CI]</span> <!-->=<!--> <!-->0.94 [0.89–0.99] per %, <em>P</em> <!-->=<!--> <!-->0.031), a < 50% LGE decrease (HR [95%CI]<!--> <!-->=<!--> <!-->3.78 [1.04–10.70], <em>P</em> <!-->=<!--> <!-->0.044) and an increase in LGE (HR [95%CI]<!--> <!-->=<!--> <!-->8.35 [2.05–24.00], <em>P</em> <!-->=<!--> <!-->0.003) were significantly associated with MACE.</p></div><div><h3>Conclusion</h3><p><span>After AM, LGE persists at 6 months in the vast majority of patients but tends to decrease. A < 50% decrease or an increase in LGE are associated with MACE, indicating that follow-up CMR is relevant for risk stratification (</span><span>Fig. 1</span>).</p></div>","PeriodicalId":8140,"journal":{"name":"Archives of Cardiovascular Diseases Supplements","volume":"15 3","pages":"Page 248"},"PeriodicalIF":18.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Cardiovascular Diseases Supplements","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1878648023001507","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Although follow-up cardiac magnetic resonance (CMR) is often performed after acute myocarditis (AM), the prognostic implications of dynamic changes in late gadolinium enhancement (LGE) are unknown. We aimed to determine the prognostic implications of dynamic LGE changes after acute AM.
Method
In a two-centre study, 204 consecutive hemodynamically stable patients (mean age 35 ± 16 years, 78.9% males) with a CMR-based diagnosis of AM were included and underwent repeat CMR 3–12 months after diagnosis. Quantitative LGE was expressed as percent of left ventricular (LV) myocardium. The primary endpoint was the occurrence of major adverse cardiac events (MACE) at median 7.3 [IQR: 5.7–8.7] years.
Results
Compared to index CMR, there was an increase in LV ejection fraction (EF) (59% vs. 55%, P < 0.001) and a decrease in LGE extent (7.6% vs. 12.0%, P < 0.001) at follow-up (mean 5.7 ± 2.6 months after index CMR). LGE persisted in 175 patients at follow-up (85.8%). LGE decreased by ≥ 50% from baseline in 94 patients (46%), by < 50% in 86 (42%) and increased in 24 (12%). Female gender (OR [95%CI] = 3.27 [1.17–9.12], P = 0.023), low baseline LVEF (OR [95%CI] = 0.93 [0.88–0.98] per %, P = 0.010) and LGE involving both septal and lateral walls (OR [95%CI] = 4.64 [1.77–12.17], P = 0.002) were independently associated with increased LGE. By multivariate Cox analysis, only baseline LVEF (HR [95%CI] = 0.94 [0.89–0.99] per %, P = 0.031), a < 50% LGE decrease (HR [95%CI] = 3.78 [1.04–10.70], P = 0.044) and an increase in LGE (HR [95%CI] = 8.35 [2.05–24.00], P = 0.003) were significantly associated with MACE.
Conclusion
After AM, LGE persists at 6 months in the vast majority of patients but tends to decrease. A < 50% decrease or an increase in LGE are associated with MACE, indicating that follow-up CMR is relevant for risk stratification (Fig. 1).
期刊介绍:
Archives of Cardiovascular Diseases Supplements is the official journal of the French Society of Cardiology. The journal publishes original peer-reviewed clinical and research articles, epidemiological studies, new methodological clinical approaches, review articles, editorials, and Images in cardiovascular medicine. The topics covered include coronary artery and valve diseases, interventional and pediatric cardiology, cardiovascular surgery, cardiomyopathy and heart failure, arrhythmias and stimulation, cardiovascular imaging, vascular medicine and hypertension, epidemiology and risk factors, and large multicenter studies. Additionally, Archives of Cardiovascular Diseases also publishes abstracts of papers presented at the annual sessions of the Journées Européennes de la Société Française de Cardiologie and the guidelines edited by the French Society of Cardiology.